- Over the years, prominent market participants have invested in R&D activities to innovate their product offerings. For example, Jennewein Biotechnologie GmbH, a functional sugars manufacturer based in Germany, collaborated with Yili.Com Inc., a dairy products manufacturer based in China, in February 2019 to research infant microbiome and human milk oligosaccharides. This strategy was designed to develop innovative, HMO-based infant formula for Chinese customers. Given the increasing market competition, such developments/strategies are likely to emerge during the forecast period
